<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p119" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_119{left:130px;bottom:1195px;letter-spacing:0.21px;}
#t2_119{left:796px;bottom:1195px;letter-spacing:0.13px;}
#t3_119{left:238px;bottom:1115px;letter-spacing:-0.01px;}
#t4_119{left:238px;bottom:1096px;letter-spacing:-0.01px;}
#t5_119{left:238px;bottom:1067px;letter-spacing:-0.01px;}
#t6_119{left:238px;bottom:1048px;letter-spacing:-0.01px;}
#t7_119{left:238px;bottom:1028px;letter-spacing:-0.01px;}
#t8_119{left:238px;bottom:1009px;letter-spacing:-0.01px;}
#t9_119{left:238px;bottom:989px;letter-spacing:-0.01px;}
#ta_119{left:238px;bottom:941px;letter-spacing:-0.01px;}
#tb_119{left:238px;bottom:922px;letter-spacing:-0.01px;}
#tc_119{left:238px;bottom:903px;letter-spacing:-0.01px;}
#td_119{left:238px;bottom:883px;letter-spacing:-0.01px;}
#te_119{left:238px;bottom:864px;letter-spacing:-0.01px;}
#tf_119{left:238px;bottom:844px;letter-spacing:-0.01px;}
#tg_119{left:128px;bottom:752px;letter-spacing:0.16px;}
#th_119{left:238px;bottom:752px;letter-spacing:-0.18px;}
#ti_119{left:141px;bottom:718px;letter-spacing:-0.1px;}
#tj_119{left:248px;bottom:719px;letter-spacing:0.25px;}
#tk_119{left:143px;bottom:661px;letter-spacing:-0.29px;}
#tl_119{left:250px;bottom:681px;letter-spacing:-0.01px;}
#tm_119{left:250px;bottom:662px;letter-spacing:-0.01px;}
#tn_119{left:248px;bottom:607px;letter-spacing:-0.04px;}
#to_119{left:141px;bottom:541px;letter-spacing:-0.1px;}
#tp_119{left:248px;bottom:542px;letter-spacing:0.25px;}
#tq_119{left:143px;bottom:485px;letter-spacing:-0.29px;}
#tr_119{left:250px;bottom:505px;letter-spacing:0.11px;}
#ts_119{left:250px;bottom:486px;letter-spacing:0.11px;}
#tt_119{left:250px;bottom:437px;letter-spacing:-0.01px;}
#tu_119{left:250px;bottom:418px;letter-spacing:-0.01px;}
#tv_119{left:250px;bottom:399px;letter-spacing:-0.01px;}
#tw_119{left:248px;bottom:363px;letter-spacing:-0.03px;}
#tx_119{left:141px;bottom:297px;letter-spacing:-0.1px;}
#ty_119{left:248px;bottom:298px;letter-spacing:0.25px;}
#tz_119{left:143px;bottom:241px;letter-spacing:-0.29px;}
#t10_119{left:250px;bottom:261px;letter-spacing:-0.01px;}
#t11_119{left:250px;bottom:242px;letter-spacing:-0.01px;}
#t12_119{left:248px;bottom:186px;letter-spacing:-0.04px;}
#t13_119{left:238px;bottom:133px;letter-spacing:-0.01px;}
#t14_119{left:238px;bottom:113px;letter-spacing:-0.01px;}
#t15_119{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_119{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_119{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_119{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_119{font-size:21px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_119{font-size:14px;font-family:NotoSans-Regular_7j-;color:#000;}
.s5_119{font-size:28px;font-family:NotoSans-Regular_7j-;color:#000;}
.s6_119{font-size:10px;font-family:NotoSans-Regular_7j-;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts119" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg119Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg119" style="-webkit-user-select: none;"><object width="908" height="1286" data="119/119.svg" type="image/svg+xml" id="pdf119" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_119" class="t s0_119">8.2. Imaging in follow-up </span><span id="t2_119" class="t s1_119">119 </span>
<span id="t3_119" class="t s2_119">Although the disease can have significant limitations compared to before the disease, patients </span>
<span id="t4_119" class="t s2_119">often require social and psychological support [416]. </span>
<span id="t5_119" class="t s2_119">The maximum follow-up intervals are 3 months for the 1st and 2nd year and 6 months for the </span>
<span id="t6_119" class="t s2_119">3rd to 5th year, even if there are no symptoms. After the 5th year, an individual decision can be </span>
<span id="t7_119" class="t s2_119">made as to whether further follow-up seems necessary. In the case of a particular risk </span>
<span id="t8_119" class="t s2_119">constellation or acute symptoms, more frequent examinations may be necessary in </span>
<span id="t9_119" class="t s2_119">collaboration with the supervising specialist colleagues, which may extend beyond 5 years. </span>
<span id="ta_119" class="t s2_119">The examinations required at each follow-up appointment include a careful and systematic </span>
<span id="tb_119" class="t s2_119">inspection of the larynx, which should also include neighboring regions such as the entire oral </span>
<span id="tc_119" class="t s2_119">cavity, the oropharynx and hypopharynx, in order to detect any metachronous secondary </span>
<span id="td_119" class="t s2_119">carcinomas in good time [127]. In addition, an examination of the neck by palpation and </span>
<span id="te_119" class="t s2_119">ultrasound is necessary. Easy-to-collect and useful clues to the possible presence of tumor </span>
<span id="tf_119" class="t s2_119">recurrence can also be determined by asking about pain and weight loss. </span>
<span id="tg_119" class="t s3_119">8.2. </span><span id="th_119" class="t s3_119">Imaging in follow-up care </span>
<span id="ti_119" class="t s4_119">8.3. </span><span id="tj_119" class="t s0_119">Consensus-based recommendation </span>
<span id="tk_119" class="t s5_119">EEC </span>
<span id="tl_119" class="t s2_119">If local recurrence is suspected or detected or if symptoms suggestive of metastases are </span>
<span id="tm_119" class="t s2_119">present, cross-sectional imaging should be performed. </span>
<span id="tn_119" class="t s6_119">Strong consensus: 100% </span>
<span id="to_119" class="t s4_119">8.4. </span><span id="tp_119" class="t s0_119">Consensus-based recommendation </span>
<span id="tq_119" class="t s5_119">EEC </span>
<span id="tr_119" class="t s1_119">In patients who have undergone surgery, cross-sectional imaging should be performed if local </span>
<span id="ts_119" class="t s1_119">recurrence is suspected or confirmed or if symptoms suggestive of metastases are present. </span>
<span id="tt_119" class="t s2_119">In patients undergoing primary radiation/chemotherapy, cross-sectional imaging to </span>
<span id="tu_119" class="t s2_119">exclude residual tumor or residual metastasis is recommended 8-12 weeks after completion </span>
<span id="tv_119" class="t s2_119">of therapy. </span>
<span id="tw_119" class="t s6_119">Majority approval: 75% </span>
<span id="tx_119" class="t s4_119">8.5. </span><span id="ty_119" class="t s0_119">Consensus-based recommendation </span>
<span id="tz_119" class="t s5_119">EEC </span>
<span id="t10_119" class="t s2_119">During follow-up, imaging and its examination intervals should be indicated depending on </span>
<span id="t11_119" class="t s2_119">the size and location of the primary tumor and the type of therapy. </span>
<span id="t12_119" class="t s6_119">Strong consensus: 100% </span>
<span id="t13_119" class="t s2_119">Imaging plays an important role in the follow-up of laryngeal carcinoma and, along with </span>
<span id="t14_119" class="t s2_119">endoscopy (microlaryngoscopy), is an important component of </span>
<span id="t15_119" class="t s0_119">Â© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
